22nd Century Group Inc Sells GVB Biopharma for $2.25 Million

Business by 2FIRSTS.ai

Nov.29.2023

22nd Century Group Inc Sells GVB Biopharma for $2.25 Million

US cigarette manufacturer, 22nd Century Group Inc, has sold its cannabis subsidiary, GVB Biopharma, for $2.25 million, exiting the industry after less than 18 months.

According to a report by Journalnow on November 29, American cigarette manufacturer 22nd Century Group Inc has announced the sale of its cannabis subsidiary, GVB Biopharma, for a sum of $2.25 million. This move signifies the company's formal exit from the cannabis industry, which proved to be a significant financial burden in less than a year and a half.

According to regulatory documents released on Monday, the purchaser of GVB is Specialty Acquisition Corp, a professional acquisition company based in Nevada.

References:

[1] 22nd Century plans to exit cannabis business at steep loss

Also Read:

[1] 22nd Century Group Plans to Publicly Issue Stock and Warrants

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

2026 InterTabac Special Coverage

2026 InterTabac Special Coverage

Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1

Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1

Imperial Brands released a trading update on April 14, reiterating its FY26 guidance and saying its 2030 transformation has started positively. The company said it still expects low-single-digit tobacco net revenue growth, double-digit NGP net revenue growth, 3.00% to 5.00% growth in Group adjusted operating profit, at least high-single-digit earnings per share growth, and at least GBP 2.2 billion in free cash flow for the full year.

Apr.14 by 2FIRSTS.ai

RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes

RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes

Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.

Alberta Seeks to Add New Vape Restrictions on Top of Existing Tobacco Framework

Alberta Seeks to Add New Vape Restrictions on Top of Existing Tobacco Framework

A new Alberta bill aimed at reducing vaping rates, especially among young people, is moving into the legislative process. Bill 208, the Vaping Reduction Act, was introduced by United Conservative Party MLA Chelsae Petrovic and appears to build on the province’s existing Tobacco, Smoking and Vaping Reduction Act. Early reporting suggests the bill could focus on disposable vapes and impose further limits on youth access to vaping products.

Apr.15 by 2FIRSTS.ai

South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes

South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes

South Korea’s Ministry of Food and Drug Safety said on April 17 that it has additionally designated the International Characterization Research Institute as a tobacco harmful components testing body under the Act on the Management of Tobacco Harmfulness. The institute has research experience in analyzing harmful components in liquid e-cigarettes and has obtained recognition for tobacco-sector ISO 17025 requirements.

Apr.17 by 2FIRSTS.ai

Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million

Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million

Ispire Technology reported financial results on May 7, 2026, for the third quarter of fiscal 2026, covering the three months ended March 31, 2026. Revenue was $18.7 million, compared with $26.2 million in the third quarter of fiscal 2025 and $20.3 million in the prior quarter. Gross profit was $2.0 million, with gross margin of 10.7%. Net loss was $9.5 million, or $0.17 per share. The company said it held $18.0 million in cash as of March 31, 2026, up $468,000 sequentially.

May.08 by 2FIRSTS.ai

Kentucky Governor Signs Tobacco, Nicotine, and Vapor Product Licensing Bill Into Law

Kentucky Governor Signs Tobacco, Nicotine, and Vapor Product Licensing Bill Into Law

A Kentucky bill relating to tobacco, nicotine, and vapor product licensing was signed by the governor on April 10, 2026, and enacted as Acts Chapter 70. The measure sets application requirements for tobacco, nicotine, and vapor product licenses, governs batch licensing, renewals, ownership changes, and denial grounds, and requires the Department of Alcoholic Beverage Control to publish application forms and related regulations within 30 days of the law’s effective date.

Apr.14 by 2FIRSTS.ai

Related Topics

HEADLINE News Company

Related Read

Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1

Imperial Brands Expects Low-Single-Digit Tobacco and NGP Net Revenue Growth in H1

RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes

RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes

Alberta Seeks to Add New Vape Restrictions on Top of Existing Tobacco Framework

Alberta Seeks to Add New Vape Restrictions on Top of Existing Tobacco Framework

South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes

South Korea Expands Tobacco Harmful Components Testing System to Cover Synthetic Nicotine Liquid Vapes

Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million

Ispire Reports Fiscal Q3 2026 Revenue of $18.7 Million and Net Loss of $9.5 Million

Kentucky Governor Signs Tobacco, Nicotine, and Vapor Product Licensing Bill Into Law

Kentucky Governor Signs Tobacco, Nicotine, and Vapor Product Licensing Bill Into Law